View Item 

Show simple item record

Lysosomal phospholipase A 2 : A novel player in host immunity to Mycobacterium tuberculosis
dc.contributor.authorSchneider, Bianca E.en_US
dc.contributor.authorBehrends, Jochenen_US
dc.contributor.authorHagens, Kristineen_US
dc.contributor.authorHarmel, Nadineen_US
dc.contributor.authorShayman, James A.en_US
dc.contributor.authorSchaible, Ulrich E.en_US
dc.date.accessioned2014-09-03T16:51:24Z
dc.date.availableWITHHELD_12_MONTHSen_US
dc.date.available2014-09-03T16:51:24Z
dc.date.issued2014-08en_US
dc.identifier.citationSchneider, Bianca E.; Behrends, Jochen; Hagens, Kristine; Harmel, Nadine; Shayman, James A.; Schaible, Ulrich E. (2014). "Lysosomal phospholipase A 2 : A novel player in host immunity to Mycobacterium tuberculosis ." European Journal of Immunology 44(8): 2394-2404.en_US
dc.identifier.issn0014-2980en_US
dc.identifier.issn1521-4141en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108269
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherMacrophagesen_US
dc.subject.otherPhospholipaseen_US
dc.subject.otherT Cellsen_US
dc.subject.otherTuberculosisen_US
dc.subject.otherImmunityen_US
dc.titleLysosomal phospholipase A 2 : A novel player in host immunity to Mycobacterium tuberculosisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108269/1/eji3032-sup-0001-FugureS1.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108269/2/eji3032-sup-0002-PeerReview.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108269/3/eji3032.pdf
dc.identifier.doi10.1002/eji.201344383en_US
dc.identifier.sourceEuropean Journal of Immunologyen_US
dc.identifier.citedreferenceFlynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schreiber, R. et al., Tumor necrosis factor‐alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995. 2: 561 – 572.en_US
dc.identifier.citedreferenceHiraoka, M., Abe, A., Lu, Y., Yang, K., Han, X., Gross, R. W. and Shayman, J. A., Lysosomal phospholipase A2 and phospholipidosis. Mol. Cell. Biol. 2006. 26: 6139 – 6148.en_US
dc.identifier.citedreferenceKorbel, D. S., Schneider, B. E. and Schaible, U. E., Innate immunity in tuberculosis: myths and truth. Microbes. Infect. 2008. 10: 995 – 1004.en_US
dc.identifier.citedreferenceWolf, A. J., Desvignes, L., Linas, B., Banaiee, N., Tamura, T., Takatsu, K. and Ernst, J. D., Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 2008. 205: 105 – 115.en_US
dc.identifier.citedreferenceUrdahl, K. B., Shafiani, S. and Ernst, J. D., Initiation and regulation of T‐cell responses in tuberculosis. Mucosal. Immunol. 2011. 4: 288 – 293.en_US
dc.identifier.citedreferenceWu, C. Y., Wang, K., McDyer, J. F. and Seder, R. A., Prostaglandin E2 and dexamethasone inhibit IL‐12 receptor expression and IL‐12 responsiveness. J. Immunol. 1998. 161: 2723 – 2730.en_US
dc.identifier.citedreferenceKatamura, K., Shintaku, N., Yamauchi, Y., Fukui, T., Ohshima, Y., Mayumi, M. and Furusho, K., Prostaglandin E2 at priming of naive CD4 + T cells inhibits acquisition of ability to produce IFN‐gamma and IL‐2, but not IL‐4 and IL‐5. J. Immunol. 1995. 155: 4604 – 4612.en_US
dc.identifier.citedreferencevan der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J. and Aarden, L. A., Prostaglandin‐E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995. 181: 775 – 779.en_US
dc.identifier.citedreferenceHarris, S. G., Padilla, J., Koumas, L., Ray, D. and Phipps, R. P., Prostaglandins as modulators of immunity. Trends Immunol. 2002. 23: 144 – 150.en_US
dc.identifier.citedreferencePaduraru, C., Bezbradica, J. S., Kunte, A., Kelly, R., Shayman, J. A., Veerapen, N., Cox, L. R. et al., Role for lysosomal phospholipase A2 in iNKT cell‐mediated CD1d recognition. Proc. Natl. Acad. Sci. USA 2013. 110: 5097 – 5102.en_US
dc.identifier.citedreferenceGadola, S. D., Silk, J. D., Jeans, A., Illarionov, P. A., Salio, M., Besra, G. S., Dwek, R. et al., Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 2006. 203: 2293 – 2303.en_US
dc.identifier.citedreferenceArora, P., Foster, E. L. and Porcelli, S. A., CD1d and natural killer T cells in immunity to Mycobacterium tuberculosis. Adv. Exp. Med. Biol. 2013. 783: 199 – 223.en_US
dc.identifier.citedreferenceEhlers, S. and Schaible, U. E., The granuloma in tuberculosis: dynamics of a host–pathogen collusion. Front. Immunol. 2012. 3: 411.en_US
dc.identifier.citedreferenceKipnis, A., Basaraba, R. J., Orme, I. M. and Cooper, A. M., Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology 2003. 109: 547 – 551.en_US
dc.identifier.citedreferenceZhou, Z., Connell, M. C. and MacEwan, D. J., TNFR1‐induced NF‐kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF‐induced ICAM‐1 and VCAM‐1 expression on endothelial cells. Cell. Signal. 2007. 19: 1238 – 1248.en_US
dc.identifier.citedreferenceRoach, D. R., Bean, A. G., Demangel, C., France, M. P., Briscoe, H. and Britton, W. J., TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 2002. 168: 4620 – 4627.en_US
dc.identifier.citedreferenceAlgood, H. M., Lin, P. L. and Flynn, J. L., Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin. Infect Dis. 2005. 41 ( Suppl 3 ): S189 – S193.en_US
dc.identifier.citedreferenceChackerian, A. A., Alt, J. M., Perera, T. V., Dascher, C. C. and Behar, S. M., Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T‐cell immunity. Infect. Immun. 2002. 70: 4501 – 4509.en_US
dc.identifier.citedreferenceVesosky, B., Rottinghaus, E. K., Stromberg, P., Turner, J. and Beamer, G., CCL5 participates in early protection against Mycobacterium tuberculosis. J. Leukoc. Biol. 2010. 87: 1153 – 1165.en_US
dc.identifier.citedreferenceSaukkonen, J. J., Bazydlo, B., Thomas, M., Strieter, R. M., Keane, J. and Kornfeld, H., Beta‐chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect. Immun. 2002. 70: 1684 – 1693.en_US
dc.identifier.citedreferenceMakino, Y., Cook, D. N., Smithies, O., Hwang, O. Y., Neilson, E. G., Turka, L. A., Sato, H. et al., Impaired T cell function in RANTES‐deficient mice. Clin. Immunol. 2002. 102: 302 – 309.en_US
dc.identifier.citedreferenceCamargo, J. F., Quinones, M. P., Mummidi, S., Srinivas, S., Gaitan, A. A., Begum, K., Jimenez, F. et al., CCR5 expression levels influence NFAT translocation, IL‐2 production, and subsequent signaling events during T lymphocyte activation. J. Immunol. 2009. 182: 171 – 182.en_US
dc.identifier.citedreferenceMolon, B., Gri, G., Bettella, M., Gomez‐Mouton, C., Lanzavecchia, A., Martinez, A. C., Manes, S. and Viola, A., T cell costimulation by chemokine receptors. Nat. Immunol. 2005. 6: 465 – 471.en_US
dc.identifier.citedreferenceTsenova, L., Mangaliso, B., Muller, G., Chen, Y., Freedman, V. H., Stirling, D. and Kaplan, G., Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis. Antimicrob. Agents Chemother. 2002. 46: 1887 – 1895.en_US
dc.identifier.citedreferenceAbe, A., Kelly, R., Kollmeyer, J., Hiraoka, M., Lu, Y. and Shayman, J. A., The secretion and uptake of lysosomal phospholipase A2 by alveolar macrophages. J. Immunol. 2008. 181: 7873 – 7881.en_US
dc.identifier.citedreferenceBancroft, G. J., Collins, H. L., Sigola, L. B. and Cross, C. E., Modulation of murine macrophage behavior in vivo and in vitro. Methods Cell Biol. 1994. 45: 129 – 146.en_US
dc.identifier.citedreferenceRoberts, M. F., Phospholipases: structural and functional motifs for working at an interface. FASEB J. 1996. 10: 1159 – 1172.en_US
dc.identifier.citedreferenceHurley, B. P. and McCormick, B. A., Multiple roles of phospholipase A2 during lung infection and inflammation. Infect. Immun. 2008. 76: 2259 – 2272.en_US
dc.identifier.citedreferenceNevalainen, T. J., Graham, G. G. and Scott, K. F., Antibacterial actions of secreted phospholipases A2. Review. Biochim. Biophys. Acta 2008. 1781: 1 – 9.en_US
dc.identifier.citedreferenceAbe, A., Hiraoka, M., Wild, S., Wilcoxen, S. E., Paine, R., 3rd and Shayman, J. A., Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages. J. Biol. Chem. 2004. 279: 42605 – 42611.en_US
dc.identifier.citedreferenceShayman, J. A., Kelly, R., Kollmeyer, J., He, Y. and Abe, A., Group XV phospholipase A, a lysosomal phospholipase A. Prog. Lipid Res. 2011. 50: 1 – 13.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
eji3032-sup-0001-FugureS1.pdf
Size:
363.5KB
Format:
PDF
View/Open
Name:
eji3032-sup-0002-PeerReview.pdf
Size:
255.8KB
Format:
PDF
View/Open
Name:
eji3032.pdf
Size:
1.503MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.